Select the type of procedure
21107656
1
Enquiry period
with
18.10.2023 17:59
to 27.10.2023 19:00
to 27.10.2023 19:00
2
Bidding period
with
27.10.2023 19:00
to 03.11.2023 14:00
to 03.11.2023 14:00
3
Auction
06.11.2023 10:00
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
4 851 510,60 MDL
Period of clarifications:
18 Oct 2023, 17:59 - 27 Oct 2023, 19:00
Submission of proposals:
27 Oct 2023, 19:00 - 3 Nov 2023, 14:00
Supplier technical support:
(+373) 79999801
Subscribe impossible
during the period Evaluation
Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2024 (repetat nr. 3)
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
18 Oct 2023, 17:52
Date modified
18 Oct 2023, 17:59
Achizitii.md ID
21107656
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 4 - Immunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml
Budget: 4663879.0 MDL
Active
Documents of the procurement procedure
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
18.10.23 17:59
Lista de distributie_LP med onco repetat nr. 3
Bidding Documents
Lista de distributie_LP med onco repetat nr. 3
18.10.23 17:59
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
18.10.23 17:59
Documentatia standard_18.10.2023.signed
Bidding Documents
Documentatia standard_18.10.2023
18.10.23 17:59
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
18.10.23 17:59
Anunt de participare_18.10.2023.signed
Bidding Documents
Anunt de participare_18.10.2023
18.10.23 17:59
Model de contract_LP med onco repetat nr. 3
Bidding Documents
Model de contract_LP med onco repetat nr. 3
18.10.23 17:59
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK